DNA extraction: the first step in programming biology

AI-generated summary

For decades DNA extraction was a lab-only technique used to identify organisms, diagnose disease, or investigate kinship. Today its role has shifted: in synthetic biology, extracting DNA is the gateway to designing new biological functions. High-quality DNA is essential for accurate sequencing, reliable gene editing (for example with CRISPR), and for synthesizing novel sequences. As biology becomes more engineering-driven—combining sequencing, AI, automation and biomanufacturing—the quality and scalability of extraction matter more, enabling automated “biofoundries” to run massive Design-Build-Test-Learn cycles and accelerate innovation.

This shift reflects four progressive capabilities: reading genomes, editing sequences, writing new DNA, and ultimately composing complete biological systems. While sequencing is now fast and cheap, the bottleneck has moved to interpreting function and predicting behavior—problems AI can help with but that still require experimental data. Companies like Ginkgo Bioworks exemplify the industrialization of biology, applying robotics and computation to program organisms for health, food, agriculture, materials and sustainability. Despite parallels with software, biological design remains harder because living systems are dynamic and unpredictable. DNA extraction remains the crucial first step on the path from studying life to designing it, even as the field works toward safely composing complex, reliable biological systems.

DNA extraction is no longer a simple laboratory technique but the first step in synthetic biology. Find out why isolating genetic material is key to sequencing, editing and designing organisms capable of transforming health, food, industry and sustainability.

For decades, DNA extraction was a technique reserved for research laboratories, hospitals, and crime departments. Its goal was to isolate genetic material to identify organisms, diagnose diseases, or reconstruct kinships. Today it is still essential for all these applications, but its role has changed radically. In the age of synthetic biology, extracting DNA no longer just means obtaining information about an organism. It means accessing the code that will allow new biological functions to be designed.

This change in perspective explains why DNA extraction has become strategically relevant. It is the first step in a technological chain that includes sequencing, artificial intelligence, automation, gene editing and, finally, biomanufacturing. Without a high-quality DNA sample, it is impossible to accurately read the genome, modify it using tools such as CRISPR or synthesize new sequences capable of giving a microorganism unprecedented functions.

The transformation is so profound that some experts are already talking about a new industrial revolution based on biology. The latest report by the Bankinter Innovation Foundation’s Future Trends Forum tells us that we have gone from studying life to starting to design it. Biology is no longer just an object of research but a technological platform on which to develop new materials, medicines, fuels or more sustainable production systems.

What is DNA extraction and why is it strategic?

Every cell contains a set of instructions encoded in a molecule made up of just four chemical bases: adenine, thymine, cytosine and guanine. This sequence constitutes DNA, the physical support where organisms store the information necessary to grow, reproduce and respond to the environment.

DNA extraction consists of separating this genetic material from the rest of the cellular components to obtain a sample pure enough to be analyzed or manipulated. For many years this process was simply a preliminary stage to other laboratory techniques. Today, however, it has become the gateway to a much broader technological ecosystem.

The reason is simple. All the tools that are driving synthetic biology are based on the same requirement: to have quality DNA. The cleaner the extraction, the greater the reliability of the sequencing and the more accurate the subsequent phases of design and gene editing will be.

From reading life to starting to design it

The history of our relationship with biology can be understood as a progression in four stages. For thousands of years, humanity used living organisms without really understanding how they worked. It fermented bread and beer with yeast, selected more productive plants, or domesticated animals long before they knew about the existence of genes.

The second stage began when we learned to read DNA. Sequencing made it possible to decipher the genetic code and understand how biological information was transmitted between generations. Later, tools capable of modifying that code arrived. Technologies such as CRISPR made it possible to edit genes with a precision that was unthinkable just two decades ago.

We are now entering a fourth phase. The goal is to design new biological systems capable of performing specific functions. In the words of the Future Trends Forum report, life is beginning to become a programmable technology.

This paradigm shift explains why DNA extraction is taking on renewed importance. It is the first link in the entire biological design chain.

Andrew Hessel and biology as programmable technology

Few people have contributed as much to explaining this transformation as Andrew Hessel, one of the experts participating in the Future Trends Forum.

Hessel has been arguing for years that biology is following a path similar to that followed by computer science during the second half of the twentieth century. If we learned to program computers then, we are now starting to program living systems.

As founder and CEO of Chromosome 24, a consultancy specializing in biological and digital continuity, Hessel works precisely on this convergence between engineering, computation, and biology. He also chairs Humane Genomics and Genome Project-write, international initiatives exploring large-scale genome design and new applications of synthetic biology.

His statement perfectly sums up the moment the sector is going through:

“Biology is becoming programmable.”

The expression may seem futuristic, but it describes a very concrete reality. Programming biology does not mean creating organisms from scratch with the ease with which a developer writes a computer application. It means using digital tools to design genetic sequences, predict their behavior, automate experiments, and build organisms capable of solving specific problems.

In this process, DNA extraction works as the initial phase of any biological engineering project. Before modifying a genome, it must be read. Before writing new sequences, existing sequences must be understood.

Reading, editing, writing… and the challenge of composing

The Future Trends Forum report proposes a very useful way of understanding the evolution of synthetic biology. It distinguishes four capabilities that reflect different levels of mastery over living systems: reading, editing, writing, and composing.

Reading consists of sequencing DNA to know the contents of a genome.

Editing involves modifying existing sequences using tools such as CRISPR.

Writing involves synthesizing new DNA and assembling longer and longer fragments to introduce additional functions.

The fourth ability is much more ambitious.

Composing means designing complete biological systems whose different components work in a coordinated manner.

Here is one of the most interesting reflections of the Nobel Prize in Chemistry Frances Arnold, patron of the Bankinter Innovation Foundation.

“We can read, we can write, we can edit. What we are still dealing with is composing.”

The comparison used by the report is particularly illuminating: a cell does not look like a line of code. It is much more like a symphony. We can read the score. We can modify some notes and even write new pieces of music. What we do not yet know how to do is compose a complete biological work capable of behaving exactly as we expect.

This difference explains why synthetic biology is advancing extremely rapidly and, at the same time, maintaining great scientific prudence.

The bottleneck is no longer in reading DNA

For years, sequencing an entire genome required months of work and huge financial investments. Today the situation is very different: next-generation sequencing technologies make it possible to read DNA with a speed and cost that was unthinkable just two decades ago.

Paradoxically, the problem is no longer to obtain genetic sequences. The real challenge is to interpret what it means. Knowing the order of millions of nitrogenous bases provides an enormous amount of information, but it does not automatically explain what function each gene plays, how thousands of proteins interact with each other or what consequences modifying a small part of the system will have.

As the Future Trends Forum report points out, the bottleneck has shifted from data generation to functional interpretation. Understanding what a genetic sequence actually does is now much more complex than obtaining it.

For this reason, artificial intelligence is beginning to play a leading role in synthetic biology. Algorithms make it possible to analyse massive amounts of information, identify patterns that are invisible to researchers and propose designs that will later have to be validated in the laboratory.

However, even the most advanced models need to start from a quality raw material. And that raw material continues to be the correctly extracted DNA.

From manual extraction to biofoundries: when biology is automated

The importance of DNA extraction lies not only in its quality, but also in its ability to scale. If the future of synthetic biology lies in designing millions of genetic variants, testing thousands of proteins or identifying the most effective combinations to produce a new drug, manual processes are no longer enough.

This is where biofoundries come into play, authentic factories of experiments that combine robotics, software, molecular biology, data analysis and artificial intelligence to automate the complete biological design cycle. Their goal is not only to work faster, but to learn faster. The Future Trends Forum report places these infrastructures as one of the great accelerators of synthetic biology by integrating the Design-Build-Test-Learn (DBTL) cycle into highly automated platforms.

In this context, DNA extraction is no longer an artisanal operation but an industrial process. Robots capable of handling liquids, automated purification systems and high-performance platforms process thousands of samples simultaneously with an accuracy that is difficult to achieve through manual procedures.

The aim is not to replace researchers, but to free them from repetitive tasks so that they can concentrate on designing new hypotheses and interpreting results.

As in other technological areas, automation multiplies the ability to experiment. If previously a team could evaluate dozens of variants in a week, now it can analyse thousands in the same period of time. This difference completely changes the speed with which knowledge advances.

Ginkgo Bioworks: programming organisms on an industrial scale

Few companies represent this transformation better than Ginkgo Bioworks.

The American company is often defined as a company dedicated to “programming organisms”, an expression that perfectly sums up the philosophy of contemporary synthetic biology. Its activity consists of designing microorganisms capable of manufacturing compounds of interest for sectors as diverse as health, agriculture, food or the chemical industry.

To achieve this, Ginkgo combines automated DNA extraction, massive sequencing, artificial intelligence, and robotic platforms capable of analyzing millions of genetic variants. Each experiment generates new data that feeds computational models, improves subsequent designs, and accelerates learning.

This approach makes it possible to develop microorganisms adapted to very specific needs: bacteria that produce ingredients for perfumery through fermentation, yeasts that synthesize molecules used in the pharmaceutical industry or microorganisms designed to improve the biological fixation of nitrogen in agriculture.

Beyond the specific cases, Ginkgo illustrates a much deeper change. Biology is beginning to be organized according to a logic typical of industrial engineering: computer-aided design, process automation, systematic validation and continuous improvement.

From the laboratory to the economy: where the impact begins

Synthetic biology is usually associated with advanced therapies or gene editing, but its scope is much greater. The Future Trends Forum report identifies several sectors where this discipline is already beginning to transform production models.

In health, the combination of sequencing, gene editing and protein design opens the door to increasingly personalized therapies. Cell and gene therapies, new antibiotics designed with the help of artificial intelligence or blood substitutes are some of the examples that are already evolving from the laboratory to clinical applications.

In food, precision fermentation makes it possible to produce proteins, fats or functional ingredients using microorganisms, reducing dependence on intensive agricultural processes. It is not only a matter of developing alternative foods, but of manufacturing ingredients with better nutritional or functional properties using fewer natural resources.

Agriculture also benefits from this revolution. Gene editing facilitates the development of crops that are more resistant to drought or certain diseases, while new microorganisms and biological solutions can reduce the use of fertilizers and plant protection products.

In the field of industry, the applications are equally promising. Biocatalysis based on engineered enzymes makes it possible to manufacture certain chemicals under more efficient conditions, while modified microorganisms can produce bioplastics, biomaterials or even contribute to the recycling of critical materials.

In all these cases there is a common element: before designing any biological solution, it is necessary to understand and manipulate the DNA that makes it possible.

Designing biology is still much more difficult than designing software

Comparisons between computer programming and biology are useful in explaining the paradigm shift, but they can also be misleading.

A computer application responds exactly to the instructions it receives. A cell does not. Living organisms evolve, interact with their environment, modify their behavior, and respond to multiple factors that we still only partially understand.

That is why synthetic biology advances in a very different way from software engineering. Each new design must be experimentally validated because there is still no “biological compiler” capable of predicting with absolute reliability how an organism will behave after introducing a genetic modification. The Future Trends Forum report itself insists on this limitation: writing DNA is now much easier than predicting the complete behavior of a living system.

This uncertainty explains the enormous value of experimental data. Artificial intelligence can propose promising designs, but it needs to be fed by results obtained in real organisms. Hence, laboratory automation and the ability to generate large volumes of biological information have become strategic assets.

Beyond DNA: Designing the Future of Biology

It is tempting to think of DNA extraction as a routine procedure, a technical step within a laboratory. However, viewed from the perspective of synthetic biology, it takes on a completely different meaning.

Extracting DNA means accessing the language with which nature stores biological information. Sequencing it allows that language to be read. Editing it makes it possible to modify existing instructions. Synthesizing new sequences opens the door to writing new functions. The next big challenge will be to learn how to compose complete biological systems capable of behaving predictably and safely.

We are still far from reaching that goal. As Frances Arnold reminds us, we know how to read, write and edit, but we are still learning to compose. Precisely therein lies the enormous complexity – and also the enormous potential – of synthetic biology.

DNA extraction will continue to be the first step on that journey. A process that began as a laboratory technique and has now become the gateway to a new way of understanding innovation: one in which biology is no longer just an object of study and gradually becomes a programmable technology.

Frequently asked

questionsWhy is DNA extraction so important in synthetic biology?

Because it provides the genetic material on which all subsequent phases are based: sequencing, gene editing, DNA synthesis and design of new biological systems.

What is the relationship between DNA extraction and tools such as CRISPR?

CRISPR allows genetic sequences to be modified with great precision, but it needs to start from DNA that is correctly identified and characterised. High-quality extraction improves the reliability of the entire process.

What are biofoundries?

They are highly automated laboratories that integrate robotics, software, artificial intelligence, and molecular biology to accelerate the design, construction, validation, and optimization of biological systems.

Which sectors will synthetic biology transform first?

The most advanced applications are concentrated in health, food, agriculture, chemistry, materials, and sustainability, although their potential impact reaches virtually any industry that uses biological processes.

What is the main challenge of synthetic biology?

More than reading or editing DNA, the big challenge is understanding how all the components of a living organism interact to design complex biological systems that function in a stable, safe, and predictable way.